Small molecule high throughput screen using AstraZeneca facilities

Funding type: Grant · Funders: Medical Research Council (MRC)

MRC ]]>

This opportunity is open to organisations with standard eligibility. Check if your organisation is eligible . Who is eligible to apply To be eligible to apply for this funding opportunity you must show that you will direct the project and be actively engaged in the work. For applicants who do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming, if it is successful: • contracts will be extended beyond the end date of the project • all necessary support for the project and the applicants will be provided, including mentorship and career development for early career researchers Demand management You can only submit one application as project lead to this funding opportunity. Resubmissions We will not accept uninvited resubmission of applications that were submitted after 1 April 2026 to Medical Research Council (MRC), the rest of UK Research and Innovation (UKRI) or any other funder. An uninvited resubmission is an application that was previously unsuccessful and has been submitted again without being invited by MRC. This includes applications that are unchanged, minimally revised, or substantially the same as the original submission. Uninvited resubmissions will be rejected. You should contact us if you are unsure whether your application is a resubmission. Find contacts in the ‘contact details’ section. Who is not eligible to apply Research applications that are led by commercial entities are not eligible. Applications may not include collaborations with additional commercial parties. You are also not eligible to apply for this funding opportunity as a project lead if you are based at an international research organisation. This does not include MRC Unit The Gambia or MRC/UVRI Uganda Research Unit at the London School of Hygiene and Tropical Medicine that are eligible to apply as project lead. Equality, diversity and inclusion We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers. We support people to work in a way that suits their personal circumstances. This includes: • career breaks • support for people with caring responsibilities • flexible working • alternative working patterns UKRI can offer disability and accessibility support for UKRI applicants and grant holders during the application and assessment process.

Primary country

🇬🇧 United Kingdom

Also eligible

None

Foreign companies

Needs verification

Local entity

Needs verification

Location condition

영국 소재 기관·기업(또는 영국 파트너와의 협업)이 일반적으로 요구됩니다(원문 확인 필요).

Document requirements were not captured (needs verification). Check the official announcement.

Application process not captured.

Evaluation process not captured.

Process steps were not captured.

Generated by local:rules-v1 · 8h ago

The announcement does not say what has to be submitted, so the disclosure exposure cannot be judged. the scope of the material requested is not stated. The awarding body is Medical Research Council (MRC). 8 fields could not be read and must be checked in the announcement and the grant agreement.

This assessment is derived from the stored announcement, document and contract fields. Anything the source does not state is marked "needs verification" — it never asserts that your idea will be taken. Generated by local:rules-v1 · 8h ago

Official URL

https://www.ukri.org/opportunity/small-molecule-high-throughput-screen-using-astrazeneca-facilities/

Application URL

https://www.ukri.org/opportunity/small-molecule-high-throughput-screen-using-astrazeneca-facilities/

Last fetched

2026.09.23

Human review

Not reviewed — check the official announcement

First seen

2026.09.10

Data status

Auto-collected, not reviewed

AI enrichment

Needs verification